The trek to the roof of the world has always been a gamble with gravity. But this week’s miracle survival of a Sherpa guide, who spent a night exposed on the South Col before being rescued, has triggered an urgent inquiry into the booming business of summit tourism. For the City’s risk managers, this is a stark reminder that when demand for an asset outstrips supply, safety margins are the first casualty.
The guide, a seasoned professional with multiple summits to his name, was left behind by his expedition team after collapsing from exhaustion near the Hillary Step. His survival against odds of minus 30 degrees and hurricane-force winds is a testament to human endurance, but it raises uncomfortable questions about the commercial pressures that now govern Everest. The number of permits issued this season hit a record 478, each costing around £11,000. Multiply that by the ancillary services oxygen, guides, logistics and you have an industry worth tens of millions. Yet the market is saturated with operators who, in the chase for shareholder returns, may be cutting corners.
This is not a moral dilemma; it is a failure of regulation. Nepal’s tourism board, which issues the permits, has long been criticised for a lack of oversight. In a market where reputational capital is everything, the inquiry will likely focus on the incentives that lead teams to push on when prudence says turn back. The guide’s employer, a well-regarded agency, insists it followed protocols. But the footnotes of the accident report will be read by insurance underwriters and liability lawyers with the same intensity as a gilt yield curve inversion.
For investors, Everest is an exotic speculative asset. The cost of a commercial expedition has risen 40% over the last decade, outstripping inflation. Yet the product is increasingly commoditised. With more climbers with less experience, the probability of tail-risk events like this one rises. The fat-tailed distribution of disaster is a concept actuaries understand all too well. The inquiry’s terms of reference will include mandatory use of satellite trackers, stricter fitness tests, and a cap on numbers. But any regulations that raise costs will be met with lobbying from trekking companies whose margins are already thin.
The survival of this guide is a call option on better risk management. Failure to act will see the premium on Everest insurance policies soar, and the market for summit tourism will eventually price in its own inefficiency. Or worse, a cascade of fatalities that forces government intervention. The bottom line: the Sherpa economy, worth an estimated £200 million annually to Nepal, cannot afford another season like this. The inquiry must deliver a framework that aligns commercial incentives with safety. Otherwise, the mountain will enforce its own discipline, and the next miracle may not arrive.
